SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-051063
Filing Date
2024-12-20
Accepted
2024-12-20 16:15:26
Documents
3
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 317206
2 proxy_001.jpg GRAPHIC 367069
3 proxy_002.jpg GRAPHIC 314476
  Complete submission text file 0001493152-24-051063.txt   1257153
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41184 | Film No.: 241568135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)